Momenta Pharmaceuticals Reports Third Quarter 2019 Financial and Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Momenta Phama (MNTA) Tops Q3 EPS by 5c
October 31, 2019 7:23 AM EDTMomenta Phama (NASDAQ: MNTA) reported Q3 EPS of ($0.45), $0.05 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $5.55 million versus the consensus estimate of $5.24 million.
Our focus in 2019 is on the execution of our clinical programs as they advance... More
